4.7 Article

Novel variants in OSGEP leading to Galloway-Mowat syndrome by altering its subcellular localization

Journal

CLINICA CHIMICA ACTA
Volume 523, Issue -, Pages 297-303

Publisher

ELSEVIER
DOI: 10.1016/j.cca.2021.10.012

Keywords

Galloway-Mowat syndrome; OSGEP; Reanalysis; Subcellular localization

Funding

  1. National Natural Science Foundation of China [81970829, 81771599, 81974240]
  2. National Key R&D Program of China [2021YFC1005302, 2017YFC1001802]
  3. Science and Technology Innovation Program of Hunan Province [2019SK1010, 2019SK1014]

Ask authors/readers for more resources

Galloway-Mowat syndrome is an extremely rare genetic disease characterized by early-onset nephrotic syndrome, microcephaly, and neurological impairment. This study identified two novel OSGEP variants and demonstrated their functional impact, expanding the spectrum of pathogenic variants associated with the syndrome.
Galloway-Mowat syndrome (GAMOS) is an extremely rare clinically heterogeneous autosomal or X-linked inherited recessive disease characterized by early-onset steroid-resistant nephrotic syndrome (SRNS), microcephaly and neurological impairment. In this study, two siblings mainly presenting with decreased head circumference, hypotonia, gross motor delay, and dysmorphic features were initially detected without pathogenic variants by karyotyping, SNP-array and WES. After a 3 year's follow-up, the proband manifested additional proteinuria, hematuria and deeper sulci with a sign of brain atrophy. By reanalysis on the proband's previous WES data, two novel compound heterozygous variants of OSGEP (c.133dupA; c.608C > T) were identified. Furthermore, functional studies showed that the variants reduced the expression of OSGEP protein and activated the DNA damage response (DDR) signaling in the lymphoblastoid cell lines (LCLs) obtained from the patient. The analysis of protein localization with confocal microscopy revealed that the EGFP-tagged/HA-tagged mutant OSGEP proteins were abnormal aggregation or retained inside the cytosol, respectively. Our study not only expanded the pathogenic variant spectrum of OSGEP but also carried on regular follow-up for kidney involvement and established a strategy for evaluation on the function of mutant OSGFP by subcellular localization assay.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.7
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available